Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992604 | PMC |
| http://dx.doi.org/10.3389/fpsyg.2020.00027 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Challenges to Applied Behavior Analysis: Introduction to the Special Issue.
Perspect Behav Sci
September 2025
Department of Educational Psychology and Leadership, Texas Tech University, Lubbock, TX USA.
Editorial: Siblinghood through any disability: the state of the art and future directions.
Front Psychol
August 2025
Department of Human and Social Sciences, University of Salento, Lecce, Italy.
The psychometric properties of the Arabic version of the Teachers' Attitudes towards Differentiated Instructional Scale.
Front Psychol
August 2025
Institute of Educational Sciences, Leuphana University Lüneburg, Lüneburg, Germany.
According to literature, teachers' attitudes are a strong predictor of their differentiated instructional practice. However, empirical research exploring teachers' attitudes, specifically towards the practice of DI, is still quite limited. Currently, there is only one instrument available that assesses teachers' attitudes towards DI, that is the Teachers' Attitudes towards Differentiated Instructional Scale (TAT-DIS), which has not been explored within any Arabian country.
View Article and Find Full Text PDFISRII 2025: Advancing equity in digital interventions across the lifespan - an introduction to this year's conference in San Diego, CA - August 4-7, 2025.
Internet Interv
September 2025
Philipps-University Marburg, Division of eHealth in Clinical Psychology, Schulstraße 12, D-35032 Marburg, Germany.
Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers.
Front Endocrinol (Lausanne)
September 2025
Congenital Hyperinsulinism International, Glen Ridge, NJ, United States.
Introduction: Congenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects that impact life and well-being.
View Article and Find Full Text PDF